Literature DB >> 16596255

Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer.

Jaw-Yuan Wang1, Ching-Sheng Yeh, Yi-Fang Chen, Chan-Hang Wu, Jan-Sing Hsieh, Tsung-Jan Huang, Sung-Yu Huang, Shiu-Ru Lin.   

Abstract

Early detection is the hallmark of successful cancer treatment. Evidence is accumulating that primary cancers begin shedding neoplastic cells in the circulation at an early stage. To date, a high-sensitivity and high-throughput method for the detection of circulating tumor cells (CTCs) is deficient. In this study, we have developed a high-sensitivity colorimetric membrane-array method to detect CTCs in the peripheral blood of colorectal cancer (CRC) patients as a potential diagnostic tool. Previously, we identified a set of 18 oligonucleotide clones, significantly overexpressed in CRC, which were synthesized and applied to a nylon membrane. Digoxigenin (DIG)-labeled cDNA were amplified by reverse transcriptase-polymerase chain reaction (RT-PCR) from the peripheral blood of 88 Taiwanese CRC patients and 50 healthy subjects, and were then hybridized to the membrane-array. Hybridization signals were detected by color development. Meanwhile, blood samples were analyzed by real-time quantitative PCR (Q-PCR). Subsequently, both methods were compared regarding their correlation, sensitivity and specificity in the detection of CTCs by statistics. The results of membrane-arrays were demonstrated to be closely related to that of Q-PCR (P<0.001). The sensitivity and specificity of membrane-arrays for the detection of CTCs were 94.3% (95% CI, 86.4-102.2%) and 94% (95% CI, 85.9-102.1%), respectively. Moreover, the accuracy of membrane-arrays is higher than that of any one gene by Q-PCR. The detection rate of membrane-arrays was significantly associated with the depth of tumor invasion (P=0.002), the presence of lymph node metastasis (P=0.016), and TNM stage (P=0.005). The preliminary results indicated that the accuracy of membrane-arrays was sufficient to distinguish Taiwanese CRC patients from normal individuals with the advantages of time-saving, cost-effectiveness and high-throughput. Thus, the constructed colorimetric membrane-array could be a promising approach for the future detection of CTCs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596255

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  16 in total

Review 1.  Screening for colorectal cancer: established and emerging modalities.

Authors:  Nikhil Pawa; Tan Arulampalam; John D Norton
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-01       Impact factor: 46.802

2.  Overexpression of S100B, TM4SF4, and OLFM4 genes is correlated with liver metastasis in Taiwanese colorectal cancer patients.

Authors:  Ming-Yii Huang; Hwei-Ming Wang; Hui-Jen Chang; Chao-Peng Hsiao; Jaw-Yuan Wang; Shiu-Ru Lin
Journal:  DNA Cell Biol       Date:  2011-10-19       Impact factor: 3.311

Review 3.  Serum tests for colorectal cancer screening.

Authors:  James Creeden; Frank Junker; Sabine Vogel-Ziebolz; Douglas Rex
Journal:  Mol Diagn Ther       Date:  2011-06-01       Impact factor: 4.074

4.  Improved real-time rt-PCR assays of two colorectal cancer peripheral blood mRNA biomarkers: a pilot study.

Authors:  Reza Yadegarazari; Taghi Hassanzadeh; Amir Majlesi; Amir Keshvari; Alireza Monsef Esfahani; Amirsasan Tootoonchi; Nooshin Shabab; Massoud Saidijam
Journal:  Iran Biomed J       Date:  2013

5.  Potential of soluble CD26 as a serum marker for colorectal cancer detection.

Authors:  Oscar J Cordero; Monica Imbernon; Loretta De Chiara; Vicenta S Martinez-Zorzano; Daniel Ayude; Maria Paez de la Cadena; F Javier Rodriguez-Berrocal
Journal:  World J Clin Oncol       Date:  2011-06-10

6.  Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse.

Authors:  C-Y Lu; Y-H Uen; H-L Tsai; S-C Chuang; M-F Hou; D-C Wu; S-H Hank Juo; S-R Lin; J-Y Wang
Journal:  Br J Cancer       Date:  2011-02-22       Impact factor: 7.640

7.  Detecting KRAS mutations in peripheral blood of colorectal cancer patients by peptide nucleic acid clamp PCR.

Authors:  Shozo Miyano; Kisaburo Hanazawa; Toshiaki Kitabatake; Minoru Fujisawa; Kuniaki Kojima
Journal:  Exp Ther Med       Date:  2012-09-03       Impact factor: 2.447

8.  Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer.

Authors:  C-Y Lu; H-L Tsai; Y-H Uen; H-M Hu; C-W Chen; T-L Cheng; S-R Lin; J-Y Wang
Journal:  Br J Cancer       Date:  2013-02-19       Impact factor: 7.640

9.  GLUT1 gene is a potential hypoxic marker in colorectal cancer patients.

Authors:  Fu-Yen Chung; Ming-Yii Huang; Ching-Sheng Yeh; Hui-Jen Chang; Tian-Lu Cheng; Li-Chen Yen; Jaw-Yuan Wang; Shiu-Ru Lin
Journal:  BMC Cancer       Date:  2009-07-20       Impact factor: 4.430

10.  Linalool Induces Cell Cycle Arrest and Apoptosis in Leukemia Cells and Cervical Cancer Cells through CDKIs.

Authors:  Mei-Yin Chang; Den-En Shieh; Chung-Chi Chen; Ching-Sheng Yeh; Huei-Ping Dong
Journal:  Int J Mol Sci       Date:  2015-11-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.